Further characterization experiments demonstrated that CD44+/CD24− mesenchymal CSCs reside at the tumor edge, have diminished E-cadherin and increased vimentin, N-cadherin, YAP signalling and EMT-related migratory pathway enrichment [180,181,182,183]. Here, CDH1 is linked to neoplasm.